Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Waskita Karya (Persero) Tbk. (WSKT)

Organon Pharma Indonesia Tbk.Trading
Waskita Karya (Persero) Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Organon Pharma Indonesia Tbk. dan Waskita Karya (Persero) Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Waskita Karya (Persero) Tbk. diperdagangkan di Rp202 (kapitalisasi pasar 5,82 T). Perbedaan utamanya: Waskita Karya (Persero) Tbk. jauh lebih besar — sekitar 55,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

SCPIWSKT
Kapitalisasi Pasar
104,4 M5,82 T

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

SCPI
Lihat detail
WSKT
Lihat detail

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI

Tentang Waskita Karya (Persero) Tbk.

The State Owned Company Waskita Karya (the Company) was established on January 1, 1961 based on Government Regulation No. 62 year 1961, from a foreign company named Volker Aanemings Maatschappij NV which nationalized by the Government of Republic Indonesia. According to Government Regulation No. 40 year 1970, the Companys status was changed from Perusahaan Negara (PN) into Perusahaan (Persero).

Selengkapnya di halaman WSKT